GENE ONLINE|News &
Opinion
Blog

Astellas Pharma
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
GeneOnline’s Weekly News Highlights: Sept 4-Sept 8
2023-09-12
Astellas Withdraws Lawsuit Against IRA but Maintains Concerns
2023-09-11
Astellas Secures Licensing Agreement with 4D Molecular Therapeutics for Gene Therapy Vector Technology
2023-07-12
FDA Approves Astellas’ Non-hormonal Menopause Treatment After Extended Review
2023-05-19
Astellas Trains Sights On Iveric Bio In $5.9 Billion Acquisition
2023-05-03
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Astellas Clears Primary Endpoints In Prostate Cancer And Menopause Trials
2023-03-14
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
Astellas’ Zolbetuximab Meets Phase 3 Endpoints In Gastric And GEJ Cancers
2022-12-16
Astellas’ Claudin 18.2 Antibody Shows Its Teeth In GEJ Cancer Trial
2022-11-17
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
EMA Begins Regulatory Review For Astellas’ Fezolinetant
2022-10-03
1 2 3
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top